Search results
Results from the WOW.Com Content Network
As the primary lobby for makers of generic drugs, [1] AAM's stated mission is to advocate for public policies that facilitate timely access to lower-cost, FDA-approved generic and biosimilar medicines by consumers and patients. Over the 10-year period 2008 through 2018, the use of generic drugs generated $2 trillion in U.S. healthcare savings.
The Medicaid drug rebate for brand name drugs, paid by drug manufacturers to the states, is increased to 23.1% (except for the rebate for clotting factors and drugs approved exclusively for pediatric use, which increases to 17.1%), and the rebate is extended to Medicaid managed care plans; the Medicaid rebate for non-innovator, multiple source ...
Amphetamine, methamphetamine and dimethylamphetamine are Schedule 2 on the California Uniform Controlled Substances Act, which is part of the California Health and Safety Code. [6] Methamphetamine is illegal for possession under Health and Safety Code 11377. Methamphetamines are illegal for possession for sale under Health and Safety Code 11378.
Voting yes on Prop. 34 is a vote in favor of stricter rules governing certain California nonprofits that participate in the federal 340B program, requiring them to spend at least 98% of their ...
The agreement also would have allowed members of Congress to opt-out of Affordable Care Act health coverage — a requirement that infuriated some GOP lawmakers — and would have let them enroll ...
The U.S. Kefauver–Harris Amendment or "Drug Efficacy Amendment" is a 1962 amendment to the Federal Food, Drug, and Cosmetic Act. It introduced a requirement for drug manufacturers to provide proof of the effectiveness and safety of their drugs before approval, [1] [2] required drug advertising to disclose accurate information about side effects, and stopped cheap generic drugs being marketed ...
President Trump signing the Executive Order, October 12, 2017. The Executive Order Promoting Healthcare Choice and Competition, also known as the Trumpcare Executive Order, or Trumpcare, [4] [5] is an Executive Order signed by Donald Trump on October 12, 2017, which directs federal agencies to modify how the Patient Protection and Affordable Care Act of the Obama Administration is implemented.
For premium support please call: 800-290-4726 more ways to reach us